Pharsight

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8133893	ANGELINI PHARMA	Trazodone and trazodone hydrochloride in purified form	Mar, 2029 (6 years from now)
CN101772490B	ANGELINI PHARMA	Purification Trazodone And Trazodone Hydrochloride Form	Jul, 2028 (5 years from now)
CN101772490A	ANGELINI PHARMA	Trazodone And Trazodone Hydrochloride In Purified Form	Jul, 2028 (5 years from now)
IN201001179P4	ANGELINI PHARMA	Trazodone And Trazodone Hydrochloride In Purified Form	Jul, 2028 (5 years from now)
IN285451B	ANGELINI PHARMA	A Process Of Production Of Purified Form Of Trazodone And Trazodone Hydrochloride	Jul, 2028 (5 years from now)
EP2178850A1	ANGELINI PHARMA	Trazodone And Trazodone Hydrochloride In Purified Form	Jul, 2028 (5 years from now)
EP2178850B1	ANGELINI PHARMA	Trazodone And Trazodone Hydrochloride In Purified Form	Jul, 2028 (5 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7829120	ANGELINI PHARMA	Trazodone composition for once a day administration	Mar, 2027 (4 years from now)

Drugs and Companies using TRAZODONE HYDROCHLORIDE ingredient

Treatment: Method of treating depression

Dosage: TABLET, EXTENDED RELEASE;ORAL

Strength	Dosage	Availability
150MG	TABLET, EXTENDED RELEASE;ORAL	Discontinued
300MG	TABLET, EXTENDED RELEASE;ORAL	Discontinued

availability in other generic markets.

Click on the highlighted region to filter.